MSP RECOVERY INC (LIFW)

US5537452097 - Common Stock

0.1397  0 (-1.2%)

Premarket: 0.1387 0 (-0.72%)

Fundamental Rating

1

Overall LIFW gets a fundamental rating of 1 out of 10. We evaluated LIFW against 115 industry peers in the Health Care Providers & Services industry. LIFW has a bad profitability rating. Also its financial health evaluation is rather negative. LIFW has a valuation in line with the averages, but on the other hand it scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year LIFW has reported negative net income.
LIFW had a negative operating cash flow in the past year.

1.2 Ratios

With a Return On Assets value of -3.00%, LIFW perfoms like the industry average, outperforming 49.12% of the companies in the same industry.
LIFW has a worse Return On Equity (-33.40%) than 62.28% of its industry peers.
Industry RankSector Rank
ROA -3%
ROE -33.4%
ROIC N/A
ROA(3y)-11.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LIFW has a Gross Margin of 66.36%. This is amongst the best in the industry. LIFW outperforms 89.47% of its industry peers.
In the last couple of years the Gross Margin of LIFW has declined.
The Profit Margin and Operating Margin are not available for LIFW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

LIFW does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LIFW has been reduced compared to 1 year ago.
Compared to 1 year ago, LIFW has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.70, we must say that LIFW is in the distress zone and has some risk of bankruptcy.
LIFW has a worse Altman-Z score (-0.70) than 74.56% of its industry peers.
LIFW has a Debt/Equity ratio of 6.75. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of LIFW (6.75) is worse than 81.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.75
Debt/FCF N/A
Altman-Z -0.7
ROIC/WACCN/A
WACC4.14%

2.3 Liquidity

A Current Ratio of 0.14 indicates that LIFW may have some problems paying its short term obligations.
LIFW's Current ratio of 0.14 is on the low side compared to the rest of the industry. LIFW is outperformed by 94.74% of its industry peers.
A Quick Ratio of 0.14 indicates that LIFW may have some problems paying its short term obligations.
LIFW's Quick ratio of 0.14 is on the low side compared to the rest of the industry. LIFW is outperformed by 93.86% of its industry peers.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.14

0

3. Growth

3.1 Past

LIFW shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.71%.
LIFW shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -55.00%.
The Revenue for LIFW have been decreasing by -17.83% on average. This is quite bad
EPS 1Y (TTM)-9.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.53%
Revenue 1Y (TTM)-55%
Revenue growth 3Y-17.83%
Revenue growth 5YN/A
Sales Q2Q%-86.73%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y264.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year203.87%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

4

4. Valuation

4.1 Price/Earnings Ratio

LIFW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 0.00, the valuation of LIFW can be described as very cheap.
Based on the Price/Forward Earnings ratio, LIFW is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.57, LIFW is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LIFW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MSP RECOVERY INC

NASDAQ:LIFW (10/28/2024, 8:00:03 PM)

Premarket: 0.1387 0 (-0.72%)

0.1397

0 (-1.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap21.66M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3%
ROE -33.4%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 66.36%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 6.75
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.14
Quick Ratio 0.14
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-9.71%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y264.17%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-55%
Revenue growth 3Y-17.83%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y